Jain Global’s Clover Health Investments CLOV Stock Holding History

Jain Global’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-403,449	Closed	-$1.45M	–	1249
2025 Q1	$1.45M	Buy	+403,449	New	+$1.62M	0.02%	399

Other funds holding CLOV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Jain Global's CLOV Position: Q2 2025 in Review

Jain Global sold out of Clover Health Investments (CLOV) in Q2 2025, closing a stake of 403,449 shares — an estimated $1.45M sold.

Jain Global first reported a position in CLOV in Q1 2025 and held it in 1 quarter. The position peaked at $1.45M in Q1 2025. 200 funds tracked by Wall St. Rank hold CLOV as of Q2 2025.

Jain Global reported no remaining Clover Health Investments position as of Q2 2025 after selling out during the quarter.
Jain Global sold 403,449 Clover Health Investments shares in Q2 2025, an estimated $1.45M.
Jain Global first reported a position in Clover Health Investments in Q1 2025 and held it in 1 quarter.
Jain Global's Clover Health Investments position peaked at $1.45M in Q1 2025.
200 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2025.

Based on Jain Global's 13F filing for Q2 2025, filed 14 Aug 2025.